These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634 [TBL] [Abstract][Full Text] [Related]
9. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study. Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799 [TBL] [Abstract][Full Text] [Related]
10. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder. Giella JG; Ring K; Olsson CA; Karp FS; Benson MC J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121 [TBL] [Abstract][Full Text] [Related]
11. Improving hexaminolevulinate enabled cancer cell detection in liquid biopsy immunosensors. Chan KM; Gleadle J; Li J; Michl TD; Vasilev K; MacGregor M Sci Rep; 2021 Mar; 11(1):7283. PubMed ID: 33790357 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1]. Rossi R; Jaeger T; Börgermann C; Furtkamp C; Moos Stahl R; Rübben H; vom Dorp F Urologe A; 2007 Sep; 46(9):1145-7. PubMed ID: 17661004 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma? Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302 [TBL] [Abstract][Full Text] [Related]
17. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER. Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626 [TBL] [Abstract][Full Text] [Related]
18. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193 [TBL] [Abstract][Full Text] [Related]
19. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer. Nakai Y; Anai S; Onishi S; Masaomi K; Tatsumi Y; Miyake M; Chihara Y; Tanaka N; Hirao Y; Fujimoto K Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):282-8. PubMed ID: 25595357 [TBL] [Abstract][Full Text] [Related]
20. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]